Haemonetics Q4 Revenue Rises 5% to $346 Million, Guides FY27 Growth of 4%-7%
The medical technology firm reported Q4 revenue growth and issued a fiscal 2027 outlook as Persona PLUS and IVT initiatives progress. Haemonetics reported fourth-quarter revenue of $346 million, a 5% increase year-over-year, with organic growth excluding CSL reaching 9%. A